ContractParticipating Site Agreement • May 16th, 2012
PARTICIPATING SITE AGREEMENT ZMLUVA O ÚČASTI KLINICKÉHO PRACOVISKA NA ŠTÚDII This Participating Site Agreement (this Táto Zmluva o účasti klinického “Agreement”) is entered into on the day of pracoviska na štúdii (ďalej ako “Zmluva”) je last signature (“Effective Date”), uzatvorená dňom posledného podpisu (“Deň platnosti”), by and between medzi Outcome Europe Sàrl, with and address at Outcome Europe Sàrl so sídlom na chemin chemin du Glapin 6, 1162 St-Prex, du Glapin 6, 1162 St-Prex, Švajčiarsko (ďalej Switzerland (hereinafter referred to as ako „Spoločnosť“), “Company”), and a Faculty Hospital Trenčín, with and address at Fakultná nemocnica Trenčín so sídlom na Legionárska 28, 911 71 Trenčín, Slovakia Legionárska 28, 911 71 Trenčín, Slovenská republika Reg. No.: 00610470 Tax Reg. No.: 2021254631 IČ: 00610470 Bank: Štátna pokladnica, Bratislava, Slovak DIČ: 2021254631 Republic Bankové spojenie: Štátna pokladnica, Account No.: 7000280438/8180 Bratislava, Slovenská republika IB
PARTICIPATING SITE AGREEMENT SMLOUVA S MÍSTEM PROVÁDĚNÍParticipating Site Agreement • December 16th, 2020
ContractParticipating Site Agreement • November 20th, 2019
PARTICIPATING SITE AGREEMENT SMLOUVA SE ZÚČASTNĚNÝM PRACOVIŠTĚM This Participating Site Agreement (“Agreement”) is by and between Fresenius Kabi Deutschland GmbH, which has a place of business at Else-Kröner-Straße 1, 61352 Bad Homburg, Germany (“Sponsor”), IQVIA Commercial GmbH & Co. OHG, having a place of business at Main Airport Center, Unterschweinstiege 2-14, 60549 Frankfurt am Main, Germany (“Company”), Fakultní nemocnicí Plzeň, located at Edvarda Beneše 1128/13, 305 99 Plzeň, Czech Republic (“Site”). Tato Smlouva se zúčastněným pracovištěm („Smlouva“) je uzavřena mezi společností Fresenius Kabi Deutschland GmbH se sídlem na adrese Else-Kröner-Straße 1, 61352 Bad Homburg, Německo („Zadavatel“), IQVIA Commercial GmbH & Co. OHG se sídlem na adrese Main Airport Center, Unterschweinstiege 2-14, 60549 Frankfurt am Main, Německo („Společnost“), Fakultní nemocnicí Plzeň, na adrese Edvarda Beneše 1128/13, 305 99 Plzeň, Česká republika („Pracoviště“). 1. Conduct of the Study. Company
ContractParticipating Site Agreement • September 4th, 2024
PARTICIPATING SITE AGREEMENT SMLOUVA O ÚČASTI CENTRA KLINICKÉHO HODNOCENÍ This Participating Site Agreement (“Agreement”) is by and between IQVIA RDS AG, Branch St- Prex, located at Route de Pallatex 29, 1162 St- Prex, Switzerland with a tax number CHE- 106.402.567, acting through its Legal representative , in hercapacity as a Director of Clinical Operations or when applicable in her capacity as a Project Manager (“Company”) and Tato smlouva o účasti Centra klinického hodnocení (dále jen „Smlouva“) je uzavírána mezi následujícími stranami: IQVIA RDS AG, Branch St-Prex, se sídlem Route de Pallatex 29, 1162 St-Prex, Švýcarsko, DIČ: CHE-106.402.567jednající prostřednictvím jejího právního zástupce paní ve své funkci ředitelky klinického provozu, případně ve své funkci projektového manažera („ Společnost “) a Motol University Hospital, state contributory organization (hereinafter referred to as “Healthcare Provider" or "Provider"), with an address at V Úvalu 84, 150 06 Praha 5, Czech Repub
ContractParticipating Site Agreement • April 2nd, 2014
AMENDMENT 1to the PARTICIPATING SITE AGREEMENT A Prospective Observational Study with protocol entitled: “LUMINOUS: Study to observe the effectiveness and safety of LUCENTIS® through individualized patient treatment and associated outcomes” Hereinafter: “the Study” BetweenFNsP F.D.Roosevelta, with address at Nám. L.Svobodu 1, 975 17 Banská Bystrica, Slovakia (hereinafter referred to as “Clinician Site”), AndDr. Mária Molnárová, with the address at FNsP F.D.Roosevelta, Nám. L.Svobodu 1, 975 17 Banská Bystrica, Slovakia(hereinafter referred to as “Investigator”), AndOutcome Europe SàrlCh. Du Glapin 61162, St.-Prex, Switzerland Hereinafter: “Company”(the parties hereinafter referred to as individually the “party” and jointly as the “parties”). WHEREAS, on June 27, 2012, the parties entered into the Participating Site Agreement for a Prospective Observational Study entitled Luminous for the conduct of the Study (the “Agreement”);¨ WHEREAS, Dr. Mária Molnárová has been designated as the pri
OWN THE BONE® PARTICIPATING SITE AGREEMENTParticipating Site Agreement • December 28th, 2020 • Illinois
This Participating Site Agreement (“Agreement”) is, by and between the American Orthopaedic Association, an Illinois Not-for-Profit Corporation with its principal place of business at 9400 W. Higgins Road, #205, Rosemont, Illinois 60018 (“AOA”) and [Institution Name] , with its principal place of business at [Institution Address]. This Agreement is effective on the date last executed below (“Effective Date”).
